logo
Roth MKM Remains a Buy on Talos Energy (TALO)

Roth MKM Remains a Buy on Talos Energy (TALO)

In a report released today, Leo Mariani from Roth MKM maintained a Buy rating on Talos Energy (TALO – Research Report), with a price target of $11.00. The company's shares closed today at $9.50.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Mariani is a top 100 analyst with an average return of 27.9% and a 63.82% success rate. Mariani covers the Energy sector, focusing on stocks such as Matador Resources, Occidental Petroleum, and Diamondback.
Talos Energy has an analyst consensus of Strong Buy, with a price target consensus of $12.63, a 32.95% upside from current levels. In a report released yesterday, Capital One Financial also initiated coverage with a Buy rating on the stock with a $14.00 price target.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Top Analyst Sees Surprising Hardware Upside for D-Wave Stock
Top Analyst Sees Surprising Hardware Upside for D-Wave Stock

Yahoo

time4 hours ago

  • Yahoo

Top Analyst Sees Surprising Hardware Upside for D-Wave Stock

D-Wave Quantum (NYSE:QBTS) gains steam as Roth MKM's Sujeeva De Silva reaffirms a Buy rating and an $18 price target, implying roughly 15 percent upside. De Silva points to accelerating traction in D-Wave's hardware businessmost notably the Advantage 2 quantum systemas the key catalyst. Warning! GuruFocus has detected 3 Warning Signs with QBTS. Revenue impact is still nascent, but the potential for $20 million-plus per unit in hardware sales marks a major leap from cloud-only offerings. D-Wave's first-ever hardware sale to Germany's Julich, valued in the tens of millions, came just six months ago; now a second deal with Yonsei University and the city of Incheon could close shortly. If Yonsei proceeds, it would signal growing enterprise confidence and unlock new, higher-value revenue streams beyond D-Wave's core cloud services. On valuation, De Silva's $18 target values QBTS at about 100 times projected 2026 saleswell above the industry average of 12 timesbut he argues the premium is justified if hardware deals accelerate. He highlights that customers' shift from experimental cloud trials to committed Advantage 2 purchases shows real-world value in D-Wave's quantum roadmap. De Silva also notes that expanding partnerships in biotech and materials science in South Korea underscore broader market interest. Why It Matters: Hardware sales could drive material revenue growth and help validate D-Wave's long-term quantum business model. This article first appeared on GuruFocus. Sign in to access your portfolio

Dassault Systemes price target lowered to EUR 27 from EUR 28 at Jefferies
Dassault Systemes price target lowered to EUR 27 from EUR 28 at Jefferies

Business Insider

time17 hours ago

  • Business Insider

Dassault Systemes price target lowered to EUR 27 from EUR 28 at Jefferies

Jefferies lowered the firm's price target on Dassault Systemes (DASTY) to EUR 27 from EUR 28 and keeps an Underperform rating on the shares. The firm says ongoing macro uncertainty means positive surprises are unlikely in the company's Q2. It believes questions over whether Dassault will meet guidance are persist until year-end. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Sarepta price target lowered to $30 from $84 at JPMorgan
Sarepta price target lowered to $30 from $84 at JPMorgan

Business Insider

time18 hours ago

  • Business Insider

Sarepta price target lowered to $30 from $84 at JPMorgan

JPMorgan lowered the firm's price target on Sarepta (SRPT) to $30 from $84 and keeps an Overweight rating on the shares. The firm made changes to its revenue assumptions for key Elevidys post the disclosure of second non-ambulatory patient death. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store